Market Research Future

Blood Coagulants Market Expanding at a Stable CAGR of 9.5% from 2016 to 2022

Middle East and Africa Blood Coagulants Market Information, by Drug Class (Coagulation Factor (Plasma-derived Factors (Factor VIII and IX, Von Willebrand Disease Factor, Prothrombin Complex and others) and Recombinant Coagulation Factors (Factor VIII and IX, Von Willebrand Disease Factor, Prothrombin Complex and others)), Vitamin K analogues, Fibrinogen Analogues and others), by Clinical Indications (Accidents, Surgery, Hemophilia and Others) - Forecast till 2022


Pune, India -- (SBWIRE) -- 09/07/2017 -- Market Synopsis of Middle East and Africa Blood Coagulants Market:
Market Scenario:
Blood Coagulants are drugs and natural factors which promote coagulation, and are used to arrest bleeding or in the treatment of bleeding disorders. Bleeding can occur due to variety of causes ranging from accidents, surgery etc. Patients of hemophilia lack natural coagulation factors and have a propensity to bleed. Bleeding tendency can also occur due to lack of platelets which may be a direct result of low nutrition, poor immunity, old age etc. Chemotherapy also affects the rate of bleeding due to depression of bone marrow and other hematopoietic (blood forming) organs.
The market for blood coagulants is growing due to factors such as increasing awareness and prevalence of bleeding disorders, rise in accidents and surgeries, rise in chemotherapy, greater screening of patients with hemophilia and other blood disorders, excellent reimbursement for these class of medicines and their inclusion in essential medicines list etc.
Taking all these factors into consideration, we expect the Middle East and Africa blood coagulants market to reach around $1784.12 million in 2022 from $ 1035 million in 2015, at a good CAGR of ~ 9.5%.

Key Players for Middle East and Africa Blood Coagulants Market:
- Shire Plc.,
- Novo Nordisk,
- Bayer AG,
- Pfizer Inc.,
- Octapharma,
- Biogen Inc.,
- CSL Behring
- others.

Request a Sample Copy @

Middle East and Africa blood coagulants market has been segmented
On the basis of drug class which comprises of coagulation factor which is further sub-segmented into plasma derived and recombinant coagulation factor; vitamin K analogues, fibrinogen analogues and others.
On the basis of clinical indications; market is segmented into accidents, surgery, hemophilia and others.

The market for blood coagulants favors companies with strong research and development and hi tech in-house skills. The market reflects an oligopolistic nature with a few players dominating the market. The entry barrier is high for new firms and substitution of one product with another manufactured by a different player is difficult. Thus due to high switching costs the market shows signs of a brand market.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on "Blood Coagulants Market Research Report- ME&A Forecast to 2022"

Browse full report @

Study Objectives Middle East and Africa Blood Coagulants Market:
- To provide detail analysis of the market structure along with forecast for the next 6 years of the various segments and sub-segments of the Middle East and Africa blood coagulants market
- To provide insights about factors affecting the market growth
- To analyze the market based on various factors- price analysis, supply chain analysis, Porters Five Force analysis etc.
- To provide historical and forecast revenue of the market segments and sub-segments for Middle East and Africa blood coagulants market
- To provide country level analysis of the market with respect to the current market size and future prospective
- To provide country level analysis of the market for segments by drug class and by clinical indication and other sub segments.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.

Table of Content

1 Introduction
1.1 Definition
1.2 Scope Of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter's Five Forces Model
4.1.1 Bargaining Power Of Suppliers
4.1.2 Bargaining Power Of Customer
4.1.3 Intensity Of Competitor's
4.1.4 Threat Of New Entrants
5 Middle East And Africa Blood Coagulants Market, By Drug Class

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312